Covered recipient · General Payments record
LEON KUJMANIAN
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2019–2025
$6,864.87
- Reported across 379 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $635.87 | 27 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $116.43 | 5 |
| DEXCOM, INC. | $116.01 | 5 |
| ABBVIE INC. | $91.73 | 4 |
| BETA BIONICS, INC. | $72.28 | 3 |
| Amgen Inc. | $60.87 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $58.40 | 2 |
| Sequel Med Tech, LLC | $43.88 | 2 |
| Madrigal Pharmaceuticals | $29.58 | 1 |
| Abbott Laboratories | $23.98 | 1 |
| Medtronic, Inc. | $22.71 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2025 201920202021202220232024
Record-level detail is published for PY2025; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $23.98 | 01/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240899460 | CMS |
| ABBVIE INC. | $31.01 | 05/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202242471 | CMS |
| ABBVIE INC. | $17.29 | 08/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202242473 | CMS |
| ABBVIE INC. | $23.17 | 09/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202242475 | CMS |
| ABBVIE INC. | $20.26 | 11/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202242477 | CMS |
| Amgen Inc. | $22.09 | 04/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228301330 | CMS |
| Amgen Inc. | $23.23 | 07/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228301328 | CMS |
| Amgen Inc. | $15.55 | 08/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228301332 | CMS |
| BETA BIONICS, INC. | $24.24 | 07/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1246813076 | CMS |
| BETA BIONICS, INC. | $24.73 | 09/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1246815082 | CMS |
| BETA BIONICS, INC. | $23.31 | 11/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1246817570 | CMS |
| Dexcom, Inc. | $15.00 | 02/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250502574 | CMS |
| Dexcom, Inc. | $22.86 | 08/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250502576 | CMS |
| Dexcom, Inc. | $34.16 | 09/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250502578 | CMS |
| Dexcom, Inc. | $19.51 | 09/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250502580 | CMS |
| Dexcom, Inc. | $24.48 | 12/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250502582 | CMS |
| Madrigal Pharmaceuticals | $29.58 | 07/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248279762 | CMS |
| Medtronic, Inc. | $22.71 | 08/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1219963463 | CMS |
| Novartis Pharmaceuticals Corporation | $31.29 | 07/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200353556 | CMS |
| Novartis Pharmaceuticals Corporation | $27.11 | 10/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200353558 | CMS |
| Novo Nordisk Inc | $23.93 | 02/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188759958 | CMS |
| Novo Nordisk Inc | $25.91 | 03/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189121741 | CMS |
| Novo Nordisk Inc | $17.94 | 04/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188830520 | CMS |
| Novo Nordisk Inc | $23.66 | 06/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188635195 | CMS |
| Novo Nordisk Inc | $24.99 | 07/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188487221 | CMS |
| Sequel Med Tech, LLC | $19.39 | 09/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1243740314 | CMS |
| Sequel Med Tech, LLC | $24.49 | 12/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1243740320 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.